Investment Research & Advisory Group, Inc.
Position in NVO — Novo Nordisk A S
CIK 1802136
ATLANTA, GA
Position in NVO
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$53,453
+$12,477 QoQ
Shares Held
1,115
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,119
of 1,348 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investment Research & Advisory Group, Inc. holds $14,457,073 across 8 Drug Manufacturers - General names. NVO ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,451 | $8,936,953 | |
| 2 | JNJ |
Johnson & Johnson
|
18,355 | $4,661,619 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,399 | $308,271 | |
| 4 | ABBV |
AbbVie Inc.
|
896 | $225,469 | |
| 5 | AMGN |
Amgen Inc
|
493 | $178,525 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
1,115 | $53,453 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
410 | $51,799 | |
| 8 | PFE |
Pfizer Inc
|
1,702 | $40,984 |
All Filings in NVO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,453 | 1,115 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $40,976 | 1,115 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $56,731 | 1,115 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $61,871 | 1,115 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $76,957 | 1,115 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $94,716 | 1,364 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $80,858 | 940 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $111,925 | 940 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $134,175 | 940 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $120,696 | 940 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $85,656 | 828 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $39,286 | 432 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $34,955 | 216 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $34,374 | 216 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $29,233 | 216 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $21,520 | 216 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $24,068 | 216 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $23,986 | 216 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $24,192 | 216 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $20,738 | 216 | Shares | Sole | 2021-10-07 | |
| No filing history on record for this holder in this stock. | ||||||